DeepHealth’s TechLive™ Gains FDA Clearance, Paving the Way for Remote Multi-Modality Imaging

DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-driven health informatics, has received FDA 510(k) clearance for its TechLive™ platform—a remote scanning solution that centralizes the operation and supervision of MR, CT, PET/CT, and Ultrasound procedures.

Developed in response to technologist shortages and rising labor costs, TechLive™ enables a single technologist to scan for multiple sites, improving operational efficiency, extending imaging center hours, and expanding access to advanced procedures. Currently, more than 300 of RadNet’s imaging systems are connected to the platform, allowing expert staff to be matched with complex cases in real time—boosting both throughput and quality.

Radiology’s workload has grown steadily over the last decade, yet the pool of qualified technologists has not kept pace. DeepHealth designed TechLive™ to address this imbalance by removing the requirement for the technologist to be physically on site.

In a pilot program spanning 64 RadNet locations in the New York area, the platform demonstrated measurable impact. Between Q2 2024 and Q2 2025, MRI room closure hours dropped by 42%, meaning more patients were able to undergo scans without delays. The remote capabilities also increased the volume of complex procedures performed, as expert technologists could be deployed instantly to challenging cases regardless of location.

The technology’s recent extension into Ultrasound adds another layer of value. Because Ultrasound is highly dependent on the operator’s skill in real time, TechLive™ now allows experienced senior sonographers and physicians to guide on-site technologists through complex examinations remotely. This capability improves the quality of scans and helps elevate the skill level of less experienced staff.

Sham Sokka, PhD, Chief Operating and Technology Officer at DeepHealth, described the approval as a transformative moment. “TechLive™ represents a paradigm shift in how we approach imaging operations,” Sokka said. “By enabling real-time remote expertise, we are not only addressing today’s staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities. This FDA clearance validates DeepHealth’s vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries.”

The platform’s scalability means that imaging providers can more effectively handle surges in demand, reduce downtime caused by staffing gaps, and ensure that patients in smaller or rural centers have access to the same expertise as those in large metropolitan hospitals. By centralizing skilled resources and applying them where they are needed most, TechLive™ aims to redefine how radiology departments operate in the face of persistent workforce shortages.

With FDA clearance secured, DeepHealth’s next step will likely involve broader rollout beyond RadNet’s own network, potentially opening new opportunities for hospitals, imaging centers, and healthcare systems seeking to modernize their imaging operations.